New monitoring method may cut surgery risks by guiding fluid use
NCT ID NCT03828565
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether continuously monitoring central venous oxygen saturation (ScvO2) during major abdominal surgery helps doctors give fluids more precisely, reducing complications. 220 patients over 50 with moderate-to-high surgical risk were randomly assigned to ScvO2-guided care or standard care. The goal was to see if this approach lowers the overall complication score at day 5 after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ScvO2 continuous monitoring with PreSep® system
- What this could lead to
- If successful, this approach could reduce post-surgery complications by better guiding fluid therapy during major abdominal surgeries.
- What could go wrong
- This is a completed trial with 220 participants, but the intervention is a monitoring procedure, not a drug, so benefits may be modest and context-dependent.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC FLOW are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Laurent Zieleskiewicz
Marseille, PACA, 13354, France